Abstract
Background & Objectives: Nitric Oxide (NO) is frequently produced by the enzyme nitric oxide synthase (NOS) and is crucial for the control and effectiveness of the cardiovascular system. However, there is a substantial reduction in NOS activity with aging that can lead to the development of hypertension and other cardiovascular obstacles. Fortunately, NO can also be produced by sequential reduction of inorganic nitrates supplementation. This proves that NO from inorganic nitrate supplements can compensate for inadequate NOS activity, thus providing cardio protective benefits.
Discussion: This review focuses on the general information about nitrous oxide, its types and mechanism of action and the fact that overview of inadequate NOS activity for cardio protective benefits was often studied for cardiovascular treatments.
Conclusion: We concluded that the natural plant NO is essential for cardiovascular activity to target site with desired concentration. Moreover, the researchers focused on evidence that suggested that nitrate supplementation could help regulate blood pressure, limit progression of atherosclerosis, and improve myocardial contractility in both healthy individuals and those with cardiovascular diseases.
Keywords: Nitric oxide, nitric oxide synthase, nitrate, nitrite, cardiovascular disease no., NOS.
Graphical Abstract
[http://dx.doi.org/10.1038/nrd2466]
[http://dx.doi.org/10.1161/01.HYP.38.2.274]
[http://dx.doi.org/10.2174/1381612013397645]
[http://dx.doi.org/10.1016/j.freeradbiomed.2011.04.042]
[http://dx.doi.org/10.1073/pnas.86.9.3375]
[http://dx.doi.org/10.1016/S0140-6736(89)91013-1]
[http://dx.doi.org/10.1152/ajpregu.00206.2010]
[http://dx.doi.org/10.1017/S0954422413000188]
[http://dx.doi.org/10.1007/s00394-015-0872-7]
[http://dx.doi.org/10.1007/s00394-011-0192-5]
[http://dx.doi.org/10.1016/j.freeradbiomed.2013.06.031] [PMID: 23806384]
[http://dx.doi.org/10.1161/ATVBAHA.110.207480]
[http://dx.doi.org/10.1161/01.RES.78.2.225]
[http://dx.doi.org/10.1249/MSS.0000000000000351]
[http://dx.doi.org/10.1016/j.niox.2014.08.014] [PMID: 25199856]
[http://dx.doi.org/10.1161/CIRCHEARTFAILURE.115.002141]
[http://dx.doi.org/10.1161/CIRCULATIONAHA.114.012957]
[http://dx.doi.org/10.1155/2016/6791519]
[http://dx.doi.org/10.14797/mdcj-15-3-200] [PMID: 31687099]
[http://dx.doi.org/10.1111/j.1753-4887.2012.00477] [PMID: 22646129]
[http://dx.doi.org/10.1111/j.1753-4887.2012.00477.x] [PMID: 22646129]
[http://dx.doi.org/10.1038/nchembio.92] [PMID: 18516050]